|
Johnson Y.N. Lau M.B.B.S. M.D. F.R.C.P. has been a member of our board of directors since November 2005. He currently serves as the Chairman of Kinex Pharmaceuticals LLC a position he has held since December 2003. Dr. Lau currently is a member of the board of directors of Chelsea Therapeutics International Ltd. (OTC BB: CHTP.OB) a publicly-held company. Prior to his position with Kinex Pharmaceuticals Dr. Lau was an independent contractor from January 2003 until December 2003 and served in various capacities at Ribapharm Inc. from August 2000 until January 2003 including Chairman President and Chief Executive Officer. Previously he was the Senior Vice President and Head of Research and Development at ICN Pharmaceuticals and Senior Director of Antiviral Therapy at Schering-Plough Research Institute. He has published over 200 scientific papers and 40 reviews and editorials in leading academic journals and was elected as a Fellow Royal College of Physicians in 2004. Dr. Lau holds an M.B.B.S. and M.D. from the University of Hong Kong and the degrees of M.R.C.P. and F.R.C.P. from the Royal College of Physicians. | 